PUBLICATIONS, NEWS & EVENTS
Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patients
“TMEM16A Potentiation: A Novel Therapeutic Approach for…
January 8, 2020/by adminTMEM16A Channel Function Does Not Influence Goblet Cell Numbers or Mucin Secretion In The Human Airway Epithelium – NACFC – Nashville – October 2019
TMEM16A Channel Function Does Not Influence Goblet Cell Numbers…
November 7, 2019/by adminEACT Increases Intracellular Calcium Levels by a Tmem16a-Independent Mechanism – NACFC – Nashville – October 2019
EACT Increases Intracellular Calcium Levels by a Tmem16a-Independent…
November 7, 2019/by adminThe In Vitro & In Vivo Pharmacology of Novel Tmem16a Potentiator Compounds – NACFC – Nashville – October 2019
The In Vitro & In Vivo Pharmacology of Novel Tmem16a Potentiator…
November 7, 2019/by adminEnterprise Therapeutics awarded up to £5.7M ($7M) from Cystic Fibrosis Foundation to Support Clinical Development of Novel Chloride Channel Modulator
Support for clinical development up to end of Phase 2 for…
October 15, 2019/by adminECFS Clinical Meeting Liverpool TMEM16A potentiator
ECFS Clinical Meeting Liverpool TMEM16A potentiator
Objectives:…
October 9, 2019/by adminObjectives:…
A systematic comparison of the profiles of inhaled ENaC blocker candidates on mucociliary clearance: are we under-dosing in clinical studies?
A systematic comparison of the profiles of inhaled ENaC blocker…
October 9, 2019/by adminSomething old and something new: ENaC & TMEM16A as targets to hydrate mucus in the CF airway
Something old and something new: ENaC & TMEM16A as targets…
October 9, 2019/by adminThe pharmacology of novel TMEM16A potentiator compounds
The pharmacology of novel TMEM16A potentiator compounds
Henry…
April 2, 2019/by adminHenry…
EACT increases intracellular calcium levels by a TMEM16A-independent mechanism
EACT increases intracellular calcium levels by a TMEM16A-independent…
April 2, 2019/by adminEnterprise Therapeutics strengthens leadership team, appoints Amit D. Munshi as Non-Executive Chairman
Appointment brings significant commercial pharma experience as…
March 25, 2019/by adminGordon Research Conference ‘Modeling and Targeting Mucociliary Function in Health and Disease: Genes to Cells to Interaction Networks and Tissues’ February 2019
Identifying pathways & compounds regulating goblet cell metaplasia…
February 20, 2019/by admin
